An FDA proposed rule that deems dietary supplements unapproved drugs when co-packaged with pharmaceutical products could put firms like Innovus Pharmaceuticals Inc. in an enforcement bullseye if made final in its current form.
Innovus in July launched tandem sales of its Apeaz OTC pain relief topical and its ArthriVarx joint health supplement, with...